Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin
- PMID: 37093
- DOI: 10.1007/BF00563108
Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin
Abstract
Chronic treatment with beta-blockers was interrupted abruptly in six patients with arterial hypertension. Three patients, who had experienced symptoms during a previous withdrawal, again complained of transient palpitations, tremor, sweating, headache and general malaise. A significant increase in standing blood pressure (BP) and heart rate (HR) was noted after 24 h. The standing HR reached a maximum after 48 h and had decreased significantly on the 7th day (p less than 0.005). There was a strong tendency to greater increase in standing BP and HR in the patients who experienced symptoms than in those who did not. Plasma concentrations of noradrenaline, adrenaline and prolactin did not change significantly. Thus, beta-blocker withdrawal symptoms are reproducible and are indicative of a transient sympathetic hyperresponse. The increased activity is not likely to be caused by increased production of circulating catecholamines, but rather by increased sensitivity of the beta-receptor.
Similar articles
-
Mechanism of propranolol withdrawal phenomena.Circulation. 1979 Jun;59(6):1158-64. doi: 10.1161/01.cir.59.6.1158. Circulation. 1979. PMID: 436208
-
Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol.Am Heart J. 1982 Aug;104(2 Pt 2):473-8. doi: 10.1016/0002-8703(82)90142-9. Am Heart J. 1982. PMID: 7102534 Clinical Trial.
-
[Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].Therapie. 1984 Jul-Aug;39(4):379-90. Therapie. 1984. PMID: 6148791 Review. French. No abstract available.
-
Effect of guanabenz withdrawal on blood pressure and plasma catecholamines.J Cardiovasc Pharmacol. 1984;6 Suppl 5:S830-2. doi: 10.1097/00005344-198400065-00020. J Cardiovasc Pharmacol. 1984. PMID: 6084134
-
The beta-adrenergic blockade withdrawal phenomenon.J Pharmacol. 1983;14 Suppl 2:35-48. J Pharmacol. 1983. PMID: 6138470 Review.
Cited by
-
The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.Br J Clin Pharmacol. 1982;13(Suppl 2):337S-343S. doi: 10.1111/j.1365-2125.1982.tb01938.x. Br J Clin Pharmacol. 1982. PMID: 6125186 Free PMC article. Review. No abstract available.
-
Drug deprescription-withdrawal risk, prevention, and treatment.Proc (Bayl Univ Med Cent). 2019 Dec 20;33(2):213-217. doi: 10.1080/08998280.2019.1695510. eCollection 2020 Apr. Proc (Bayl Univ Med Cent). 2019. PMID: 32313464 Free PMC article. Review.
-
Communicate with cancer patients: 2. Handling uncertainty, collusion, and denial.BMJ. 1988 Oct 15;297(6654):972-4. doi: 10.1136/bmj.297.6654.972. BMJ. 1988. PMID: 3142573 Free PMC article.
-
Preoperative depression symptom severity and its impact on adherence to preoperative beta-blocker therapy.J Cardiothorac Vasc Anesth. 2014 Dec;28(6):1467-73. doi: 10.1053/j.jvca.2014.05.006. Epub 2014 Sep 26. J Cardiothorac Vasc Anesth. 2014. PMID: 25263776 Free PMC article.
-
Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.Eur J Clin Pharmacol. 1981 Jan;19(2):83-8. doi: 10.1007/BF00568393. Eur J Clin Pharmacol. 1981. PMID: 6110540 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources